V. Rochemont

Type de document

Co-auteur

G. Vassalli

A. Smith

L.K. Segesser

M. Samaja

A. Sabine

T. V. Petrova

G. Milano

M.J. Meens

O. Lyons

B.R. Kwak

I. Kutkut

F. Kiefer

F.R. Kaladji

S. Hugues

S. Hendrikx

M. Guazzi

J. Dubrot

A.F. Corno

P. Bianciardi

J. Bernier-Latmani

Date

Source

Serveur académique Lausannois (2)

Mot-clé

Toleration (2) tolérance (2) administration (1) test (1) risque (1) protéine (1) morphologie (1) acide (1) marqueur (1) lipide (1) exposition (1) air (1) drainage (1) ADN (1) adulte (1) jeune (1) Handling (1) Morphology (1) Drama (1) Sildenafil (1) Apolipoprotein E (1) Atherosclerotic plaque (1) Apoptosis (1) Nitric oxide (1) Cyclic nucleotide phosphodiesterases (1) Valves (1) T cells (1) State, The (1) Serum (1) Risk (1)

Documents écrit par V. Rochemont (2) | parle de V. Rochemont (0)

Cx47 fine-tunes the handling of serum lipids but is dispensable for lymphatic vascular function.

M.J. Meens et al. (2017)

Phosphodiesterase-5 inhibition mimics intermittent reoxygenation and improves cardioprotection in the hypoxic myocardium.

G. Milano et al. (2011)